Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

Fig. 2

3D representation of the main principal components obtained after PCA for (A) the 68 protein spots found to distinguish CSF samples from patients with Relapse–remitting multiple sclerosis (RRMS) and other inflammatory diseases of the CNS (INF), using the Student’s t-test; (B) the 52 protein spots found to distinguish samples from patients with Relapse–remitting multiple sclerosis (RRMS) and non-inflammatory diseases of the CNS (N-INF), as determined by the Student’s t-test; and (C) the 52 protein spots found to distinguish samples obtained from patients with Relapse–Remitting multiple sclerosis (RRMS) vs. other inflammatory and non-inflammatory diseases of the CNS (INF and N-INF), as determined by the Student’s t test

Back to article page